Varicella-zoster virus (VZV) is a widespread human herpes virus causing chicken pox on primary infection and persisting in sensory neurons. Reactivation causes shingles, which are characterized by severe pain and often lead to postherpetic neuralgia. To elucidate the mechanisms of VZV-associated hyperalgesia, we elaborated an in vitro model for the VZV infection of sensory neurons from rat dorsal root ganglia. Between 35 and 50% of the neurons showed strong expression of the immediate-early virus antigens IE62 and IE63 and the late glycoprotein gE. When the intracellular calcium concentration was monitored microfluorometrically for individual cells after infection, the sensitivity to GABA or capsaicin was similar in controls and in VZV-infected neurons. However, the baseline calcium concentration was increased. Neurons became de novo sensitive to adrenergic stimulation after VZV infection. Norepinephrine-responsive neurons were more frequent and calcium responses to norepinephrine were significantly higher after infection with wild-type isolates than with the attenuated vaccine strain OKA. The adrenergic agonists phenylephrine and isoproterenol had similar efficacy. We suggest that the infection with wild-type VZV isolates confers norepinephrine sensitivity to sensory neurons by using Varicella-zoster virus (VZV) causes chicken pox on primary infection usually in childhood. The virus persists in sensory neurons of trigeminal and dorsal root ganglia (DRG) (1). After latency for many decades, the virus can be reactivated and cause shingles (herpes zoster). This reactivation may result in severe complications, including encephalitis or myelitis, with high mortality or long-term morbidity. Zoster morbidity increases with age; particularly in the elderly, severe zoster pain and postherpetic neuralgia are frequent. Approximately 300,000 cases of shingles occur annually in the U.S. in immunocompetent persons (2). The incidence of shingles is even higher in immunodeficient patients in whom complications are more severe (3). It is still controversial as to what extent immunization with the VZV vaccine strain OKA (reviewed in refs 4, 5) influences the rate of herpes zoster and postherpetic neuralgia decades after the vaccination. The potential of the vaccine to cause zoster and neuralgia is not well characterized due to lack of long-term experience. Moreover, it is unclear whether vaccine-induced immunity will be sufficient to prevent infection with pathogenic wild-type isolates many years after vaccination.
zoster pain and postherpetic neuralgia are frequent. Approximately 300,000 cases of shingles occur annually in the U.S. in immunocompetent persons (2) . The incidence of shingles is even higher in immunodeficient patients in whom complications are more severe (3) . It is still controversial as to what extent immunization with the VZV vaccine strain OKA (reviewed in refs 4, 5) influences the rate of herpes zoster and postherpetic neuralgia decades after the vaccination. The potential of the vaccine to cause zoster and neuralgia is not well characterized due to lack of long-term experience. Moreover, it is unclear whether vaccine-induced immunity will be sufficient to prevent infection with pathogenic wild-type isolates many years after vaccination.
Aiming at a better understanding of zoster pain, we focused on virus-induced changes in the nervous system. The persisting virus is located in neurons but probably not in perineuronal satellite cells in sensory ganglia (1, 6, 7) . VZV replication in culture is highly cell-associated and slow in comparison to herpes simplex virus (HSV). The DNA sequence of a VZV laboratory strain carries 69 open reading frames, most of which have homologous genes in HSV (8) . Functional changes in sensory neurons after HSV infection have been described. HSV affected all classes of afferent fibers and DRG neurons (9) . After HSV infection, decreased excitability and reduced action potential firing were observed that were antagonized by acyclovir (10) . Comparable data are not available for VZV since the virus has a pronounced species specificity. An in vitro model for latent VZV infection of rat DRG neurons has been described (11) , but the available in vivo VZV infection models in rats and guinea pigs so far have not been appropriate for studying acute VZV-induced changes in neuron function (12) (13) (14) (15) (16) . Only recently, however, a rat behavioral model for VZV-induced allodynia and hyperalgesia was developed in the rat that seems to closely resemble symptoms of severe pain observed in humans (17) .
To study functional changes in VZV-infected neurons underlying zoster pain, we introduced novel culture conditions allowing the efficient infection of rat DRG neurons. The cells show signs of lytic virus replication and express the viral immediate-early proteins IE62, IE63 and the late glycoprotein gE. In individual neurons, microfluorometric measurements allowed us to describe a gain-of-function after VZV infection with a de novo sensitivity to the pain-associated neurotransmitter norepinephrine. In contrast to a series of wild-type VZV isolates, the vaccine strain OKA yielded a strongly reduced norepinephrine sensitivity.
MATERIALS AND METHODS

Primary neuron culture
Details of dissociation procedures have been published elsewhere (18) . Briefly, lumbar DRG (thoracic segment T13 to lumbar L5) were harvested from adult female Wistar rats (100 to 160 g) from an inbred colony. After dissection, the ganglia were transferred into Dulbecco's modified Eagle medium (DMEM, Gibco, Karlsruhe, Germany) supplemented with 50 g/ml gentamicin (Sigma, Deisenhofen, Germany). The connective tissue was removed and the ganglia were treated with collagenase (0.28 U/ml in DMEM, 75 min; Roche Biochemicals, Mannheim, Germany) and, after two washes, with trypsin (25,000 U/ml in DMEM, 12 min; Sigma). After dissociation with a fire-polished Pasteur pipette, the cells were sedimented and finally resuspended in culture medium. After plating on glass coverslips coated with poly-l-lysine (200 g/ml, Sigma), the cells were cultivated in serum-free TNB 100 medium (Biochrom, Berlin, Germany) supplemented with penicillin/streptomycin (each 200 U/ml; Gibco), Lglutamine (2 mM; Gibco), and nerve growth factor (mouse NGF 7S, 100 ng/ml; Alomone Labs, Tel Aviv, Israel) at 37°C in a humidified atmosphere containing 5% CO 2 .
Virus cultures and infection of neurons by cocultivation
Primary human foreskin fibroblasts (passage 9 to 20) were cultivated in the presence of 5% CO 2 in DMEM supplemented with heat-inactivated fetal bovine serum (10%), Lglutamine (2 mM), and gentamicin (100 g/ml, all from Gibco). The fibroblasts were split by ratio 1:2 once a week. A series of VZV strains was used: NIK, a clinical isolate shown before to latently infect rats in vivo (kindly provided by Catherine Sadzot-Delvaux, Liège, Belgium; ref 12); HJO, a clinical isolate from a zoster lesion of the ear; PJ, a clinical isolate from a thoracic zoster lesion; vaccine strain OKA, derived from the commercial vaccine material (Varilrix, SmithKline Beecham, Munich, Germany); and parental strain OKA, kindly provided at low passage number by Paul Kinchington (Pittsburgh, Pa.). The various virus strains were passaged once a week on fresh fibroblasts (0.5ϫ10 5 cells on 25 cm 2 ) that had been trypsinized and split within 1 h before infection. For this purpose, infected cultures with 30 -50% cytopathogenic effect were trypsinized and transferred to the fresh fibroblasts at the split ratios 1:100, 1:50, 1:25, and 1:12.5. After 1 wk, either the 1:100 or the 1:50 culture was used for the next passage.
For the infection of rat DRG neurons by coculture, infected cultures with 30 -50% cytopathogenic effect (typically the 1:12.5 or 1:25 split cultures) were trypsinized on day 4 after splitting. The infected cells (ϳ0.5ϫ10 5 ) were centrifuged, washed, and resuspended in 2 ml medium. Freshly prepared rat DRG cells were plated as a droplet (100 l, ϳ300 neuronal cells per culture, in supplemented TNB 100) onto poly-l-lysine coated round coverslips (in 24-well plates) or petri dishes (35 mm diameter with glass bottom). Infected fibroblasts were added to the droplet in a volume of 30 l (ϳ7500 cells per culture). The microcultures were kept in 130 l for 4 h in humidified atmosphere at 37°C. Supplemented serum-free TNB 100 medium was then added. After 48 h cocultivation, fibroblasts were no longer detectable in the cultures.
Immunocytochemistry
After 2 days in culture, the cells were fixed for 15 min with Zamboni's fixative (150 ml saturated picric acid, 20 g paraformaldehyde, and 850 ml phosphate buffer pH 7.4; ref 19 ). The coverslips were stored at Ϫ20°C. For immunocytochemical staining, the coverslips were warmed to room temperature in phosphate-buffered saline (PBS) for 10 min. Some coverslips were incubated with a directly labeled VZV-specific monoclonal antibody for 30 min to detect viral antigens (nonspecified VZV-specific fluorescein isothiocyanate-conjugated monoclonal antibody; BioWhittaker, Walkersville, Md.). Indirect immunofluorescence was performed to detect the viral proteins IE62, IE63, and gE. The monoclonal 8616 was used for demonstrating IE62 and the monoclonal 8612 was applied for gE (both from Chemicon, Temecula, Calif.). A polyvalent rabbit antiserum was used to demonstrate IE63 (kindly provided by Catherine Sadzot-Delvaux, Liège, Belgium; ref 12). In the first step, the respective antibody was applied in the presence of 10% fetal bovine serum, 0.5% Triton X-100, 1% normal goat serum, and human immunoglobulins (Cohn's fraction II, 2 mg/ml; Sigma) in PBS for 24 h at 4°C. After three washes in saline containing 1% normal goat serum, appropriate secondary antibodies coupled to fluorescein isothiocyanate (1:50, goat anti-mouse) or to the red fluorescent Cy3 (1:330; goat anti-rabbit, both from Dianova, Hamburg, Germany) were applied in the presence of 1% normal goat serum and human immunoglobulins (Cohn's fraction II, 2 mg/ml) in PBS for 30 min at room temperature. After three washes in PBS with 1% normal goat serum and 0.5% Triton X-100, the coverslips were mounted on glass slides with glycerol jelly (Merck, Darmstadt, Germany) and analyzed with a fluorescence microscope (Leica, Heidelberg, Germany) equipped with a video camera, frame grabber, and a software program for image analysis, which was developed in-house and modified for this purpose.
Calcium measurements in isolated neurons from dorsal root ganglia
The external solution contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose, and 10 mM HEPES buffer pH 7.3. For stimulation, 1 M capsaicin (freshly diluted from a 3 mM stock solution in 98% ethanol) and gamma amino butyric acid (GABA, 30 M freshly diluted from a 30 mM stock solution in distilled water) were added to normal external solution. Norepinephrine, phenylephrine, and isoproterenol were freshly dissolved in external solution and used in final concentrations of 100 M. For calcium measurements, 3 M FURA-2/AM (Molecular Probes, Leiden, The Netherlands) was added to the extracellular solution for 30 min. After 30 min of washout in normal extracellular solution, the cultures were transferred to the recording microscope where only a single cell was analyzed per culture. Background-corrected fluorescence images were taken with a slow scan CCD camera system with fast monochromator (PTI, New Jersey) coupled to an Axiovert microscope with an ϫ40 fluotar oil immersion objective (Zeiss, Oberkochen, Germany). Fura-2 was excited at 340 and 380 nm wavelengths (). The fluorescence was collected at Ͼ 420 nm at a frequency of 1 Hz with equal exposure time of 200 ms.
[Ca 2ϩ ] i was calculated as previously published (20, 21) and the calibration constants obtained in vitro were R min ϭ 0.44, R max ϭ 8.0, and K eff ϭ 1.2 M. For chemical stimulation, a fast 10-channel system with common outlet was used for drug application (22) . The magnetic valves were controlled manually from a switchboard and the time constants for a full exchange of solution were ϳ 150 ms.
Data analysis
For detailed statistical analysis, the CSS software package was used (StatSoft, Tulsa, Okla.). All summarizing results are given as means Ϯ se. For intraindividual data comparisons, the Wilcoxon matched pairs test was calculated, if not stated otherwise, and differences were considered significant at P Ͻ 0.05.
RESULTS
Infection of rat DRG neurons by VZV
By cocultivation with permissively infected human fibroblasts, freshly prepared rat DRG neurons were infected with VZV. The efficacy of this infection was monitored by immunofluorescence staining against virus epitopes. Two days after infection with the wildtype isolate NIK, many non-neuronal cells were stained with the direct VZV-specific immunofluorescence procedure. These cells were not further analyzed, but seemed to represent satellite cells. Approximately onethird of the neurons were stained with the fluorescent VZV-specific monoclonal reagent. Neuronal cell death was not detectable at this time. When the cultures were incubated for a longer time, more cells were stained and many of them lost their healthy appearance. At 3-4 days after infection, most of the neurons had already died.
With the indirect immunofluorescence procedure using the anti-IE62 monoclonal antibody, ϳ35% of the neurons infected with NIK were stained ( Fig. 1; see Fig.  2 ). All these cells were colabeled with a rabbit antiserum against IE63, which stained a higher proportion of the neurons (ϳtwo-thirds of neurons, Fig. 1 ). Similar percentages of labeled neurons were observed in cultures infected with the wild-type isolate HJO. There was no difference in staining rates or intensities between different wild-type isolates and the vaccine strain OKA (Fig. 2) . The monoclonal antibody against the virusspecific glycoprotein gE also stained approximately one-third of the neurons. The percentage of immunolabeled neurons suggests that a minimum of one-third of the neurons in the cocultures were infected by VZV after 2 days of cocultivation.
Functional changes of DRG neurons after VZV cocultivation
VZV-infected neuron cultures were functionally tested in comparison to noninfected cells. Only a single cell per culture dish was analyzed. At 3 days after infection or with higher concentrations of virus-infected fibroblasts, most neuron-like structures had lost all sensitivity to the physiological stimuli used (GABA, capsaicin) and therefore were considered nonfunctional or dead. Two days after infection, many functions were unchanged in the infected neuron cultures. Voltage-dependent currents were recorded in five neurons from infected cultures using the whole-cell voltage-clamp configuration of the patch-clamp technique (21, 23) . No pronounced alteration in inward or outward currents was observed. Similarly, neuronal responsiveness to GABA or capsaicin was unaltered in infected cultures as compared to controls. In contrast, the baseline calcium concentration which was 114 Ϯ 6 nM in control neurons (nϭ38) was significantly increased in neurons from cultures infected with wild-type isolates or with the vaccine strain (136Ϯ5 nM [NIK, nϭ77] As expected, most control neurons were insensitive to norepinephrine application and only 1 of 38 control neurons responded to adrenergic stimulation, with a peak rise in [Ca 2ϩ ] i of 54 nM. In contrast, in cultures infected with wild-type isolates (NIK, HJO, PJ, and parental OKA), ϳ50% of small-sized capsaicin-sensitive neurons were also sensitive to norepinephrine and this percentage was higher than in controls or OKA vaccine strain-infected cultures (1 of 38 neurons and 17%, Fig.  3a and Table 1 ). The magnitude of the calcium increase was significantly higher (ranging from 97Ϯ26 nM to 148Ϯ50 nM for wild-type isolates) than in controls (1.5Ϯ1.5 nM) or in the OKA vaccine strain (15Ϯ5 nM, all PՅ0.05, Fig. 3b ). Cultures infected with the parental OKA strain showed intermediate sensitivity: although ϳ50% of neurons responded to norepinephrine, the average magnitude of the responses was only 65 Ϯ 16 nM, and this was not significantly different from the OKA vaccine strain. Norepinephrine sensitivity was predominantly induced in capsaicin-sensitive neurons. Only exceptionally capsaicin-insensitive but GABA-sensitive neurons responded to norepinephrine. In five neurons, repetitive stimulation with norepinephrine was performed. Figure 4 demonstrates that the responses were prone to pronounced tachyphylaxis. The third application yielded only about one-third of the response magnitude determined for the first stimulation.
To prove that the norepinephrine sensitivity was induced in infected neurons, five norepinephrine-sensitive neurons were incubated with a fluorescent Cy3-coupled monoclonal antibody against the virus-specific surface protein gE in the recording chamber for direct immunostaining without fixation. However, none of the tested neurons carried detectable amounts of gE on their surface. Under these conditions, mainly dead neurons were labeled by surface staining with Cy3-antigE. Therefore, in another series of norepinephrine sensitive neurons, indirect immunocytochemistry for IE63 was performed after fixation in the recording chamber. Three of the five neurons that were sensitive to norepinephrine could be stained with the antibody against IE63, whereas none of the five insensitive neurons was stained (Fig. 5) .
Adrenergic receptor subtypes involved in VZV-related norepinephrine sensitivity
To determine which adrenergic receptor subtypes were functionally expressed in the infected neuron cultures, the ␣a 1 receptor agonist phenylephrine and/or the ␤b 1 receptor agonist isoproterenol were tested, since these receptor subtypes are known to be coupled to second messenger pathways that cause rises in [ receptors, and ϳ15% express both receptors, whereas ϳ36% were insensitive to both agonists (12 of 33) . This lack of sensitivity may be explained by the tachyphylaxis of the response, since the agonists were always applied after a preceding norepinephrine stimulus.
To determine the source of the calcium increase, experiments were performed in calcium-free extracellular solution. In most cells, the calcium responses were still preserved in the absence of extracellular calcium (Fig. 6) . This independence from extracellular calcium ions suggests that calcium is released from intracellular stores, which is in line with the known signal transduction pathways for the ␣ 1 receptor subtype and, according to recent findings, for the ␤ 1 receptor subtype also.
DISCUSSION
The present study reports a novel cellular model for the acute neuronal VZV infection that confers norepineph- rine sensitivity to predominantly nociceptive DRG neurons from the rat in culture. After 2 days, the basal calcium levels were increased in infected cultures as compared to controls and ϳ50% of the capsaicinsensitive neurons infected with wild-type VZV isolates expressed functional ␣ 1 -and/or ␤ 1 -adrenergic receptors, leading to an increase in [Ca 2ϩ ] i on adrenergic stimulation. Such changes were significantly less pronounced in cultures infected with the OKA vaccine strain, suggesting that the up-regulation of adrenergic receptor expression and the development of zoster or postherpetic neuralgia could be substantially reduced in patients who experience VZV reactivation and zoster symptoms caused by the vaccine virus.
In our system of neuronal VZV infection, up to 50% of the neurons expressed virus-specific proteins after 2 days of cocultivation. At this time, neuronal cell death was not detectable and the infected cells appeared fully viable, because they reacted appropriately to various stimuli. The neuron cultures seemed to be permissive to the virus: gE was expressed on the surface of a fraction of infected cells and in a high percentage of cells after fixation and permeabilization. Moreover, after 3 days or at higher virus concentrations, only a few neurons survived. These neurons presented in an unhealthy condition and the majority of the neuron-like structures responded to none of the routinely used stimuli (i.e., they were insensitive to GABA, norepinephrine, or capsaicin). This rapid loss of functional cells together with the expression of virus antigens argues for virus-induced lytic cell death, which could possibly be augmented by virus-induced apoptosis (24) . Therefore, the presented infection system cannot be applied to study virus latency, but seems appropriate to investigate effects from acute and productive infection. The observed changes seem to be similar to the situation in the patient, where reactivation and virus replication cause severe pain.
Infection with HSV, another ␣-herpes virus, does not induce comparable long-lasting forms of neuralgia or severe pain, but rather is characterized by prodromal and lesion-related episodes of pain and itching. In a cellular model, HSV infection has been shown to reduce the excitability of sensory neurons and to cause a loss of tetrodotoxin-sensitive action potentials developing during 5 to 15 h postinfection (10) . In contrast to these findings, we demonstrate that the infection with wild-type VZV strains causes a gain-of-function and confers a de novo sensitivity to adrenergic agonists to DRG neurons. Under normal conditions, this cell type does not respond to norepinephrine. However, adrenergic effects are characteristic of other neuropathic changes in nociceptive neurons: adrenergic effects have also been reported in other models of neuropathic pain, such as nerve ligation or axotomy (25) (26) (27) (28) (29) .
In patients with postherpetic neuralgia, the injection of adrenergic agonists induced pain and allodynia. Even when postherpetic neuralgia had been present for years, injection of adrenergic agonists into the skin increased the pain substantially, most likely through direct activation of C-nociceptors (30) . In addition, treatment with sympatholytic drugs or sympathectomy improved the severe pain in many cases (31) . These findings are in line with the present data showing that VZV-infected DRG neurons in culture become sensitive to adrenergic stimulation. Therefore, we hypothesized that an up-regulation of adrenergic receptors could be the functional correlate for zoster pain. The culture system was also used to investigate which subtypes of adrenergic receptors are up-regulated in VZV-infected neurons. In the past, the expression of receptor subtypes on DRG neurons had been controversially discussed. In many studies, ␣ 2 receptors have been suggested to contribute to neuropathy (28) . However, they are coupled to second messenger pathways, which decrease intracellular calcium levels. In the present study, results with pharmacological agonists suggest that ␣ 1 -and, to a lesser extent, ␤ 1 receptors are involved in the norepinephrine-induced calcium release. These two receptor subtypes are coupled to signal cascades, which are able to increase the intracellular calcium concentration (32, 33) . The preserved increase in [Ca 2ϩ ] i under calcium-free conditions further supports an ␣ 1 receptor-mediated mechanism; this is also favored by the pronounced tachyphylaxis of the responses, which may be due to depletion of intracellular calcium stores. Pain and hyperalgesia are consistent with rises in [Ca 2ϩ ] i , and an increase in intracellular calcium concentration plays a role especially in heat sensitization of nociceptors and heat hyperalgesia (23) . Such heat hyperalgesia is one of the symptoms of zoster/postherpetic neuralgia and may be explained by the present findings (30) .
An attenuated vaccine strain OKA was developed in order to prevent primary infection leading to chicken pox (reviewed in ref 5) . In the present study, the OKA vaccine strain infected the neuron cultures in a similar way as the wild-type isolates. There was no obvious difference in the number of infected neurons between the vaccine strain and wild-type isolates. Similar to other infectious agents (34, 35) , VZV infection weakly mobilized intracellular calcium in the cultivated neurons, irrespectively of the virus isolate or strain tested. This is consistent with previous reports revealing biological differences between vaccine OKA and other VZV strains only in special contexts, such as defective accumulation of gC or reduced skin tropism in SCID-hu mice (16, 36) . However, healthy children who have received the OKA vaccine strain develop immunity, usually without signs of disease and with a low rate of minor side effects (4, 5) . The OKA vaccine strain seemed to decrease the incidence of zoster and associated neuralgia (5, 37) . Our data further argue in favor of the safety of this live vaccine. The degree of sensitivity to adrenergic stimulation was much higher in wildtype VZV isolates than in the OKA vaccine strain. The lower number of norepinephrine-sensitive cells and the smaller response magnitudes observed in cultures infected with the OKA vaccine strain could presumably generate a lower incidence or intensity of neuropathic pain upon reactivation of the vaccine virus.
Although the DNA sequence of a VZV laboratory strain is available (8) , the genome structures of the OKA vaccine or parental strains or of wild-type isolates are largely unknown. Presently, there is no hint for a genetic correlate of the viral phenotype causing norepinephrine sensitivity after infection of sensory neurons. The presented infection system supplies a unique tool to study mutant viruses in order to reveal the genetic basis leading to the up-regulation of adrenoreceptors. Such mechanisms may also have implications for other types of neuropathic pain that involve adrenoreceptors in nociceptive neurons. 
